img

Global Melbine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Melbine Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Melbine market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Melbine market research.
Key manufacturers engaged in the Melbine industry include Xi'an ruixi Biological Technological Co.L, Sino-american Shanghai Squibb Pharmaceutical Co. LTD, Shenzhen Zhonglian Pharmaceutical Co., Ltd., Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd, Shijiazhuang Xinhua Pharmaceutical Co., Ltd., Beijing Liling Hengtai Drug Co., Ltd., AstraZeneca, MIMS and Chengdu Hengrui Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Melbine were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Melbine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Melbine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Xi'an ruixi Biological Technological Co.L
Sino-american Shanghai Squibb Pharmaceutical Co. LTD
Shenzhen Zhonglian Pharmaceutical Co., Ltd.
Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd
Shijiazhuang Xinhua Pharmaceutical Co., Ltd.
Beijing Liling Hengtai Drug Co., Ltd.
AstraZeneca
MIMS
Chengdu Hengrui Pharmaceutical
Merck Healthcare KGaA
Shandong Sibang Pharmaceutical Co. LTD
Hebei Samshi Pharmaceutical Co. LTD
Yuekang Pharmaceutical Group Co. LTD
Qingdao Huanghai Pharmaceutical Co. LTD
Guizhou Tian 'an Pharmaceutical Co. LTD
Segment by Type
Sustained Release Tablet
Enteric Coatel Tablets

Segment by Application


Medicine
Chemistry

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Melbine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Melbine Market Overview
1.1 Product Overview and Scope of Melbine
1.2 Melbine Segment by Type
1.2.1 Global Melbine Market Value Comparison by Type (2024-2034)
1.2.2 Sustained Release Tablet
1.2.3 Enteric Coatel Tablets
1.3 Melbine Segment by Application
1.3.1 Global Melbine Market Value by Application: (2024-2034)
1.3.2 Medicine
1.3.3 Chemistry
1.4 Global Melbine Market Size Estimates and Forecasts
1.4.1 Global Melbine Revenue 2018-2034
1.4.2 Global Melbine Sales 2018-2034
1.4.3 Global Melbine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Melbine Market Competition by Manufacturers
2.1 Global Melbine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Melbine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Melbine Average Price by Manufacturers (2018-2023)
2.4 Global Melbine Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Melbine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Melbine, Product Type & Application
2.7 Melbine Market Competitive Situation and Trends
2.7.1 Melbine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Melbine Players Market Share by Revenue
2.7.3 Global Melbine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Melbine Retrospective Market Scenario by Region
3.1 Global Melbine Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Melbine Global Melbine Sales by Region: 2018-2034
3.2.1 Global Melbine Sales by Region: 2018-2023
3.2.2 Global Melbine Sales by Region: 2024-2034
3.3 Global Melbine Global Melbine Revenue by Region: 2018-2034
3.3.1 Global Melbine Revenue by Region: 2018-2023
3.3.2 Global Melbine Revenue by Region: 2024-2034
3.4 North America Melbine Market Facts & Figures by Country
3.4.1 North America Melbine Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Melbine Sales by Country (2018-2034)
3.4.3 North America Melbine Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Melbine Market Facts & Figures by Country
3.5.1 Europe Melbine Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Melbine Sales by Country (2018-2034)
3.5.3 Europe Melbine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Melbine Market Facts & Figures by Country
3.6.1 Asia Pacific Melbine Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Melbine Sales by Country (2018-2034)
3.6.3 Asia Pacific Melbine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Melbine Market Facts & Figures by Country
3.7.1 Latin America Melbine Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Melbine Sales by Country (2018-2034)
3.7.3 Latin America Melbine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Melbine Market Facts & Figures by Country
3.8.1 Middle East and Africa Melbine Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Melbine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Melbine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Melbine Sales by Type (2018-2034)
4.1.1 Global Melbine Sales by Type (2018-2023)
4.1.2 Global Melbine Sales by Type (2024-2034)
4.1.3 Global Melbine Sales Market Share by Type (2018-2034)
4.2 Global Melbine Revenue by Type (2018-2034)
4.2.1 Global Melbine Revenue by Type (2018-2023)
4.2.2 Global Melbine Revenue by Type (2024-2034)
4.2.3 Global Melbine Revenue Market Share by Type (2018-2034)
4.3 Global Melbine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Melbine Sales by Application (2018-2034)
5.1.1 Global Melbine Sales by Application (2018-2023)
5.1.2 Global Melbine Sales by Application (2024-2034)
5.1.3 Global Melbine Sales Market Share by Application (2018-2034)
5.2 Global Melbine Revenue by Application (2018-2034)
5.2.1 Global Melbine Revenue by Application (2018-2023)
5.2.2 Global Melbine Revenue by Application (2024-2034)
5.2.3 Global Melbine Revenue Market Share by Application (2018-2034)
5.3 Global Melbine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Xi'an ruixi Biological Technological Co.L
6.1.1 Xi'an ruixi Biological Technological Co.L Corporation Information
6.1.2 Xi'an ruixi Biological Technological Co.L Description and Business Overview
6.1.3 Xi'an ruixi Biological Technological Co.L Melbine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Xi'an ruixi Biological Technological Co.L Melbine Product Portfolio
6.1.5 Xi'an ruixi Biological Technological Co.L Recent Developments/Updates
6.2 Sino-american Shanghai Squibb Pharmaceutical Co. LTD
6.2.1 Sino-american Shanghai Squibb Pharmaceutical Co. LTD Corporation Information
6.2.2 Sino-american Shanghai Squibb Pharmaceutical Co. LTD Description and Business Overview
6.2.3 Sino-american Shanghai Squibb Pharmaceutical Co. LTD Melbine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sino-american Shanghai Squibb Pharmaceutical Co. LTD Melbine Product Portfolio
6.2.5 Sino-american Shanghai Squibb Pharmaceutical Co. LTD Recent Developments/Updates
6.3 Shenzhen Zhonglian Pharmaceutical Co., Ltd.
6.3.1 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Corporation Information
6.3.2 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Melbine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Melbine Product Portfolio
6.3.5 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd
6.4.1 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Corporation Information
6.4.2 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Description and Business Overview
6.4.3 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Melbine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Melbine Product Portfolio
6.4.5 Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Recent Developments/Updates
6.5 Shijiazhuang Xinhua Pharmaceutical Co., Ltd.
6.5.1 Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Corporation Information
6.5.2 Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Melbine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Melbine Product Portfolio
6.5.5 Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Beijing Liling Hengtai Drug Co., Ltd.
6.6.1 Beijing Liling Hengtai Drug Co., Ltd. Corporation Information
6.6.2 Beijing Liling Hengtai Drug Co., Ltd. Description and Business Overview
6.6.3 Beijing Liling Hengtai Drug Co., Ltd. Melbine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Beijing Liling Hengtai Drug Co., Ltd. Melbine Product Portfolio
6.6.5 Beijing Liling Hengtai Drug Co., Ltd. Recent Developments/Updates
6.7 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Melbine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca Melbine Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 MIMS
6.8.1 MIMS Corporation Information
6.8.2 MIMS Description and Business Overview
6.8.3 MIMS Melbine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 MIMS Melbine Product Portfolio
6.8.5 MIMS Recent Developments/Updates
6.9 Chengdu Hengrui Pharmaceutical
6.9.1 Chengdu Hengrui Pharmaceutical Corporation Information
6.9.2 Chengdu Hengrui Pharmaceutical Description and Business Overview
6.9.3 Chengdu Hengrui Pharmaceutical Melbine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Chengdu Hengrui Pharmaceutical Melbine Product Portfolio
6.9.5 Chengdu Hengrui Pharmaceutical Recent Developments/Updates
6.10 Merck Healthcare KGaA
6.10.1 Merck Healthcare KGaA Corporation Information
6.10.2 Merck Healthcare KGaA Description and Business Overview
6.10.3 Merck Healthcare KGaA Melbine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Merck Healthcare KGaA Melbine Product Portfolio
6.10.5 Merck Healthcare KGaA Recent Developments/Updates
6.11 Shandong Sibang Pharmaceutical Co. LTD
6.11.1 Shandong Sibang Pharmaceutical Co. LTD Corporation Information
6.11.2 Shandong Sibang Pharmaceutical Co. LTD Melbine Description and Business Overview
6.11.3 Shandong Sibang Pharmaceutical Co. LTD Melbine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Shandong Sibang Pharmaceutical Co. LTD Melbine Product Portfolio
6.11.5 Shandong Sibang Pharmaceutical Co. LTD Recent Developments/Updates
6.12 Hebei Samshi Pharmaceutical Co. LTD
6.12.1 Hebei Samshi Pharmaceutical Co. LTD Corporation Information
6.12.2 Hebei Samshi Pharmaceutical Co. LTD Melbine Description and Business Overview
6.12.3 Hebei Samshi Pharmaceutical Co. LTD Melbine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hebei Samshi Pharmaceutical Co. LTD Melbine Product Portfolio
6.12.5 Hebei Samshi Pharmaceutical Co. LTD Recent Developments/Updates
6.13 Yuekang Pharmaceutical Group Co. LTD
6.13.1 Yuekang Pharmaceutical Group Co. LTD Corporation Information
6.13.2 Yuekang Pharmaceutical Group Co. LTD Melbine Description and Business Overview
6.13.3 Yuekang Pharmaceutical Group Co. LTD Melbine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Yuekang Pharmaceutical Group Co. LTD Melbine Product Portfolio
6.13.5 Yuekang Pharmaceutical Group Co. LTD Recent Developments/Updates
6.14 Qingdao Huanghai Pharmaceutical Co. LTD
6.14.1 Qingdao Huanghai Pharmaceutical Co. LTD Corporation Information
6.14.2 Qingdao Huanghai Pharmaceutical Co. LTD Melbine Description and Business Overview
6.14.3 Qingdao Huanghai Pharmaceutical Co. LTD Melbine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Qingdao Huanghai Pharmaceutical Co. LTD Melbine Product Portfolio
6.14.5 Qingdao Huanghai Pharmaceutical Co. LTD Recent Developments/Updates
6.15 Guizhou Tian 'an Pharmaceutical Co. LTD
6.15.1 Guizhou Tian 'an Pharmaceutical Co. LTD Corporation Information
6.15.2 Guizhou Tian 'an Pharmaceutical Co. LTD Melbine Description and Business Overview
6.15.3 Guizhou Tian 'an Pharmaceutical Co. LTD Melbine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Guizhou Tian 'an Pharmaceutical Co. LTD Melbine Product Portfolio
6.15.5 Guizhou Tian 'an Pharmaceutical Co. LTD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Melbine Industry Chain Analysis
7.2 Melbine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Melbine Production Mode & Process
7.4 Melbine Sales and Marketing
7.4.1 Melbine Sales Channels
7.4.2 Melbine Distributors
7.5 Melbine Customers
8 Melbine Market Dynamics
8.1 Melbine Industry Trends
8.2 Melbine Market Drivers
8.3 Melbine Market Challenges
8.4 Melbine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Melbine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Melbine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Melbine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Melbine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Melbine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Melbine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Melbine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Melbine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Melbine, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Melbine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Melbine, Product Type & Application
Table 12. Global Key Manufacturers of Melbine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Melbine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melbine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Melbine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Melbine Sales by Region (2018-2023) & (K Units)
Table 18. Global Melbine Sales Market Share by Region (2018-2023)
Table 19. Global Melbine Sales by Region (2024-2034) & (K Units)
Table 20. Global Melbine Sales Market Share by Region (2024-2034)
Table 21. Global Melbine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Melbine Revenue Market Share by Region (2018-2023)
Table 23. Global Melbine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Melbine Revenue Market Share by Region (2024-2034)
Table 25. North America Melbine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Melbine Sales by Country (2018-2023) & (K Units)
Table 27. North America Melbine Sales by Country (2024-2034) & (K Units)
Table 28. North America Melbine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Melbine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Melbine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Melbine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Melbine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Melbine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Melbine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Melbine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Melbine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Melbine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Melbine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Melbine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Melbine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Melbine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Melbine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Melbine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Melbine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Melbine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Melbine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Melbine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Melbine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Melbine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Melbine Sales (K Units) by Type (2018-2023)
Table 51. Global Melbine Sales (K Units) by Type (2024-2034)
Table 52. Global Melbine Sales Market Share by Type (2018-2023)
Table 53. Global Melbine Sales Market Share by Type (2024-2034)
Table 54. Global Melbine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Melbine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Melbine Revenue Market Share by Type (2018-2023)
Table 57. Global Melbine Revenue Market Share by Type (2024-2034)
Table 58. Global Melbine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Melbine Price (US$/Unit) by Type (2024-2034)
Table 60. Global Melbine Sales (K Units) by Application (2018-2023)
Table 61. Global Melbine Sales (K Units) by Application (2024-2034)
Table 62. Global Melbine Sales Market Share by Application (2018-2023)
Table 63. Global Melbine Sales Market Share by Application (2024-2034)
Table 64. Global Melbine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Melbine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Melbine Revenue Market Share by Application (2018-2023)
Table 67. Global Melbine Revenue Market Share by Application (2024-2034)
Table 68. Global Melbine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Melbine Price (US$/Unit) by Application (2024-2034)
Table 70. Xi'an ruixi Biological Technological Co.L Corporation Information
Table 71. Xi'an ruixi Biological Technological Co.L Description and Business Overview
Table 72. Xi'an ruixi Biological Technological Co.L Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Xi'an ruixi Biological Technological Co.L Melbine Product
Table 74. Xi'an ruixi Biological Technological Co.L Recent Developments/Updates
Table 75. Sino-american Shanghai Squibb Pharmaceutical Co. LTD Corporation Information
Table 76. Sino-american Shanghai Squibb Pharmaceutical Co. LTD Description and Business Overview
Table 77. Sino-american Shanghai Squibb Pharmaceutical Co. LTD Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Sino-american Shanghai Squibb Pharmaceutical Co. LTD Melbine Product
Table 79. Sino-american Shanghai Squibb Pharmaceutical Co. LTD Recent Developments/Updates
Table 80. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Corporation Information
Table 81. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Melbine Product
Table 84. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Corporation Information
Table 86. Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Description and Business Overview
Table 87. Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Melbine Product
Table 89. Jiangsu Zhengda Tianqing Pharmaceutical Group Co., Ltd Recent Developments/Updates
Table 90. Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Corporation Information
Table 91. Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Melbine Product
Table 94. Shijiazhuang Xinhua Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Beijing Liling Hengtai Drug Co., Ltd. Corporation Information
Table 96. Beijing Liling Hengtai Drug Co., Ltd. Description and Business Overview
Table 97. Beijing Liling Hengtai Drug Co., Ltd. Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Beijing Liling Hengtai Drug Co., Ltd. Melbine Product
Table 99. Beijing Liling Hengtai Drug Co., Ltd. Recent Developments/Updates
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. AstraZeneca Melbine Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. MIMS Corporation Information
Table 106. MIMS Description and Business Overview
Table 107. MIMS Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. MIMS Melbine Product
Table 109. MIMS Recent Developments/Updates
Table 110. Chengdu Hengrui Pharmaceutical Corporation Information
Table 111. Chengdu Hengrui Pharmaceutical Description and Business Overview
Table 112. Chengdu Hengrui Pharmaceutical Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Chengdu Hengrui Pharmaceutical Melbine Product
Table 114. Chengdu Hengrui Pharmaceutical Recent Developments/Updates
Table 115. Merck Healthcare KGaA Corporation Information
Table 116. Merck Healthcare KGaA Description and Business Overview
Table 117. Merck Healthcare KGaA Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Merck Healthcare KGaA Melbine Product
Table 119. Merck Healthcare KGaA Recent Developments/Updates
Table 120. Shandong Sibang Pharmaceutical Co. LTD Corporation Information
Table 121. Shandong Sibang Pharmaceutical Co. LTD Description and Business Overview
Table 122. Shandong Sibang Pharmaceutical Co. LTD Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Shandong Sibang Pharmaceutical Co. LTD Melbine Product
Table 124. Shandong Sibang Pharmaceutical Co. LTD Recent Developments/Updates
Table 125. Hebei Samshi Pharmaceutical Co. LTD Corporation Information
Table 126. Hebei Samshi Pharmaceutical Co. LTD Description and Business Overview
Table 127. Hebei Samshi Pharmaceutical Co. LTD Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Hebei Samshi Pharmaceutical Co. LTD Melbine Product
Table 129. Hebei Samshi Pharmaceutical Co. LTD Recent Developments/Updates
Table 130. Yuekang Pharmaceutical Group Co. LTD Corporation Information
Table 131. Yuekang Pharmaceutical Group Co. LTD Description and Business Overview
Table 132. Yuekang Pharmaceutical Group Co. LTD Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Yuekang Pharmaceutical Group Co. LTD Melbine Product
Table 134. Yuekang Pharmaceutical Group Co. LTD Recent Developments/Updates
Table 135. Qingdao Huanghai Pharmaceutical Co. LTD Corporation Information
Table 136. Qingdao Huanghai Pharmaceutical Co. LTD Description and Business Overview
Table 137. Qingdao Huanghai Pharmaceutical Co. LTD Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Qingdao Huanghai Pharmaceutical Co. LTD Melbine Product
Table 139. Qingdao Huanghai Pharmaceutical Co. LTD Recent Developments/Updates
Table 140. Guizhou Tian 'an Pharmaceutical Co. LTD Corporation Information
Table 141. Guizhou Tian 'an Pharmaceutical Co. LTD Description and Business Overview
Table 142. Guizhou Tian 'an Pharmaceutical Co. LTD Melbine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Guizhou Tian 'an Pharmaceutical Co. LTD Melbine Product
Table 144. Guizhou Tian 'an Pharmaceutical Co. LTD Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Melbine Distributors List
Table 148. Melbine Customers List
Table 149. Melbine Market Trends
Table 150. Melbine Market Drivers
Table 151. Melbine Market Challenges
Table 152. Melbine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Melbine
Figure 2. Global Melbine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Melbine Market Share by Type in 2024 & 2034
Figure 4. Sustained Release Tablet Product Picture
Figure 5. Enteric Coatel Tablets Product Picture
Figure 6. Global Melbine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Melbine Market Share by Application in 2024 & 2034
Figure 8. Medicine
Figure 9. Chemistry
Figure 10. Global Melbine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 11. Global Melbine Market Size (2018-2034) & (US$ Million)
Figure 12. Global Melbine Sales (2018-2034) & (K Units)
Figure 13. Global Melbine Average Price (US$/Unit) & (2018-2034)
Figure 14. Melbine Report Years Considered
Figure 15. Melbine Sales Share by Manufacturers in 2024
Figure 16. Global Melbine Revenue Share by Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Melbine Players: Market Share by Revenue in 2024
Figure 18. Melbine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 19. Global Melbine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 20. North America Melbine Sales Market Share by Country (2018-2034)
Figure 21. North America Melbine Revenue Market Share by Country (2018-2034)
Figure 22. United States Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe Melbine Sales Market Share by Country (2018-2034)
Figure 25. Europe Melbine Revenue Market Share by Country (2018-2034)
Figure 26. Germany Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific Melbine Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific Melbine Revenue Market Share by Region (2018-2034)
Figure 33. China Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. China Taiwan Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Indonesia Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Thailand Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Malaysia Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Latin America Melbine Sales Market Share by Country (2018-2034)
Figure 43. Latin America Melbine Revenue Market Share by Country (2018-2034)
Figure 44. Mexico Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Brazil Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Argentina Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Melbine Sales Market Share by Country (2018-2034)
Figure 48. Middle East & Africa Melbine Revenue Market Share by Country (2018-2034)
Figure 49. Turkey Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Saudi Arabia Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. UAE Melbine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Melbine by Type (2018-2034)
Figure 53. Global Revenue Market Share of Melbine by Type (2018-2034)
Figure 54. Global Melbine Price (US$/Unit) by Type (2018-2034)
Figure 55. Global Sales Market Share of Melbine by Application (2018-2034)
Figure 56. Global Revenue Market Share of Melbine by Application (2018-2034)
Figure 57. Global Melbine Price (US$/Unit) by Application (2018-2034)
Figure 58. Melbine Value Chain
Figure 59. Melbine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed